We’re not done with chemotherapy, so why not improve it?
While it's hard to get excited about a modified chemotherapy drug in an era of personalized medicine, checkpoint inhibitors, and CAR-T immunotherapies, Modra Pharmaceuticals' modified taxane drugs could make a sizeable impact in the field.